Overview
Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, also known as Hay-Wells syndrome, is a rare genetic disorder belonging to the group of ectodermal dysplasias caused by mutations in the TP63 gene. It is characterized by a distinctive triad of features: ankyloblepharon filiforme adnatum (thin strands of tissue connecting the upper and lower eyelids at birth), ectodermal defects, and cleft lip and/or cleft palate. The ectodermal abnormalities affect structures derived from the ectoderm, including the skin, hair, nails, teeth, and sweat glands. Skin findings are particularly prominent and can include severe, chronic skin erosions that may be present at birth and resemble a scalded appearance, especially on the scalp. Hair is typically sparse, wiry, and coarse, and nails may be dystrophic or absent. Dental anomalies include small, widely spaced, or missing teeth. Reduced sweating (hypohidrosis) due to sweat gland involvement can lead to heat intolerance. The skin erosions in AEC syndrome can be extensive and debilitating, sometimes persisting for years and posing a risk of secondary infection. Additional features may include lacrimal duct abnormalities, hearing loss, limb anomalies such as syndactyly, and occasionally genitourinary malformations. Growth and intellectual development are typically normal, though chronic skin disease can significantly impact quality of life. Treatment of AEC syndrome is symptomatic and multidisciplinary. Cleft lip and palate are managed surgically. Skin erosions require careful wound care, infection prevention, and sometimes specialized dressings. Dental abnormalities may require prosthetic intervention. Patients benefit from coordinated care involving dermatologists, plastic surgeons, ophthalmologists, otolaryngologists, and dentists. Genetic counseling is recommended for affected families. There is currently no cure or targeted therapy for the underlying genetic defect.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome.
Community
No community posts yet. Be the first to share your experience with Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome.
Start the conversation →Latest news about Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
No recent news articles for Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
What is Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome?
Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome, also known as Hay-Wells syndrome, is a rare genetic disorder belonging to the group of ectodermal dysplasias caused by mutations in the TP63 gene. It is characterized by a distinctive triad of features: ankyloblepharon filiforme adnatum (thin strands of tissue connecting the upper and lower eyelids at birth), ectodermal defects, and cleft lip and/or cleft palate. The ectodermal abnormalities affect structures derived from the ectoderm, including the skin, hair, nails, teeth, and sweat glands. Skin findings are particularly pro
How is Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome inherited?
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome typically begin?
Typical onset of Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome is neonatal. Age of onset can vary across affected individuals.